Literature DB >> 2124040

Cocaine- and methamphetamine-induced acute cerebral vasospasm: an angiographic study in rabbits.

A M Wang1, J N Suojanen, V M Colucci, C L Rumbaugh, N K Hollenberg.   

Abstract

Stroke is a frequently reported, though uncommon, complication of drug abuse, primarily cocaine. The pathogenesis is uncertain, although such cerebrovascular events may result from sympathetically mediated vasoconstriction of cerebral vessels. Amphetamine, another sympathomimetic amine that is commonly abused, may also cause strokes by producing cerebral vasospasm and/or vasculitis. Amphetamine and its derivatives are frequent adulterants of illegally obtained cocaine and may also be used concurrently; the effect(s) of this combination of drugs upon the cerebral vasculature is not known. Our aim was to develop an animal model that would enable us to study the ability of these drugs to produce acute cerebral vasospasm and to observe the response to IV administration of amphetamine and cocaine, either alone or together. Magnified basilar artery arteriograms were obtained in 12 New Zealand white rabbits before and after IV administration of cocaine, methamphetamine, or both, at various dosages. Low doses produced mild vasodilatation. At higher doses, the animals who received cocaine and methamphetamine alone showed little or no basilar artery spasm, but coadministration produced definite basilar artery vasospasm, reflecting a synergistic vasoconstrictive effect. If a similar response exists in the human cerebral vasculature, then this could help explain the cause of strokes associated with drug abuse.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124040      PMCID: PMC8332147     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  12 in total

1.  Substance Abuse, Hepatitis C, and Aging in HIV: Common Cofactors that Contribute to Neurobehavioral Disturbances.

Authors:  Randi Melissa Schuster; Raul Gonzalez
Journal:  Neurobehav HIV Med       Date:  2012-02-16

2.  Absence of acute cerebral vasoconstriction after cocaine-associated subarachnoid hemorrhage.

Authors:  Tibor Boco; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

3.  Peripheral ammonia as a mediator of methamphetamine neurotoxicity.

Authors:  Laura E Halpin; Bryan K Yamamoto
Journal:  J Neurosci       Date:  2012-09-19       Impact factor: 6.167

Review 4.  Breakdown of Blood-Brain and Blood-Spinal Cord Barriers During Acute Methamphetamine Intoxication: Role of Brain Temperature.

Authors:  Eugene A Kiyatkin; Hari S Sharma
Journal:  CNS Neurol Disord Drug Targets       Date:  2016       Impact factor: 4.388

Review 5.  Neurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamine.

Authors:  Laura E Halpin; Stuart A Collins; Bryan K Yamamoto
Journal:  Life Sci       Date:  2013-07-24       Impact factor: 5.037

Review 6.  Cocaine use and stroke.

Authors:  Sean D Treadwell; Tom G Robinson
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

7.  Neurochemical alterations in methamphetamine-dependent patients treated with cytidine-5'-diphosphate choline: a longitudinal proton magnetic resonance spectroscopy study.

Authors:  Sujung J Yoon; In Kyoon Lyoo; Hengjun J Kim; Tae-Suk Kim; Young Hoon Sung; Namkug Kim; Scott E Lukas; Perry F Renshaw
Journal:  Neuropsychopharmacology       Date:  2009-12-30       Impact factor: 7.853

8.  In vivo cerebrovascular effects of cocaine- and amphetamine-regulated transcript (CART) peptide.

Authors:  Jeffrey J Iliff; Nabil J Alkayed; Kiarash J Golshani; Jason Weinstein; Richard J Traystman; G Alexander West
Journal:  J Cardiovasc Pharmacol       Date:  2008-07       Impact factor: 3.105

Review 9.  Clinical perspectives on ischemic stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Exp Neurol       Date:  2021-01-10       Impact factor: 5.330

Review 10.  Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.

Authors:  Arthur N Westover; Ethan A Halm
Journal:  BMC Cardiovasc Disord       Date:  2012-06-09       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.